首页 > 市场调查报告书 > 製药

消化器

全球消化不良药物市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测

市场调查报告书

商品编码

1421055

全球消化不良药物市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测

Global Dyspepsia Drugs Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年01月01日 | 出版商:

Value Market Research | 英文 225 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

全球消化不良药物市场需求预计将从 2023 年的 103 亿美元达到 2032 年近 164.1 亿美元的市场规模，2024-2032 年研究期间CAGR为 5.31%。

消化不良药物是指用于缓解消化不良症状的药物或药物治疗，消化不良是一种常见的消化系统疾病，其特征是上腹部不适或疼痛。消化不良，通常被称为消化不良，可表现为腹胀、打嗝、噁心以及餐中或餐后饱腹感等症状。这些药物旨在缓解这些症状并改善整体消化健康。

市场动态

消化不良药物市场是由消化不良流行的因素所驱动的，消化不良是一种常见的消化系统疾病，其特征是腹部不适和消化不良等症状。现代生活方式，包括不规则的饮食习惯和高压力水平，会导致消化不良症状的发生，从而推动对缓解药物的需求。胃食道逆流症和消化性溃疡等胃肠道疾病往往与消化不良并存，进一步提振了市场。人口老化和饮食习惯的改变促进了全球需求，尤其是老年人的需求。提高意识、改善诊断以及某些药物的非处方药供应在推动市场成长方面发挥关键作用。药物开发方面持续的技术进步、对联合疗法的关注以及以患者为中心的医疗保健方法进一步促进了消化不良药物市场的动态格局。随着个人寻求针对消化不适的有效药理学解决方案，市场以创新配方和客製化治疗来应对，以满足不同患者的需求。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球消化不良药物市场的各个细分市场进行了包容性评估。消化不良药物产业的成长和趋势为本研究提供了整体方法。

市场区隔

消化不良药物市场报告的这一部分提供了国家和区域层面细分市场的详细资料，从而帮助策略家确定相应产品或服务的目标人群以及即将到来的机会。

按指示

功能性消化不良
器质性消化不良

依药物类型

质子帮浦抑制剂
H-2-受体拮抗剂
抗酸剂
抗生素
促动力
抗忧郁药

透过药物治疗

品牌化
通用的

按模式

在柜檯
处方

按配销通路

零售药局
医院药房
网路药局

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲消化不良药物市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。消化不良药物市场的主要参与者包括武田製药有限公司、阿斯特捷利康公司、Salix Pharmaceuticals Inc.、雅培实验室、辉瑞公司、赛诺菲公司、宝洁公司、Haleon plc、ANI Pharmaceuticals Inc.、雷迪博士实验室有限公司。该部分包含竞争格局的整体视图，其中包括各种策略发展，例如关键併购、未来能力、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

简介 - 市场动态
市场驱动因素
市场限制
机会
产业动态
波特五力分析
市场吸引力分析
- 按指标进行的市场吸引力分析
- 按药物类型分類的市场吸引力分析
- 药物市场吸引力分析
- 按模式分類的市场吸引力分析
- 按配销通路分類的市场吸引力分析
- 市场吸引力分析：按地区

第 4 章：价值链分析

价值链分析
原料分析
- 原料清单
- 原料厂商清单
- 主要原物料价格走势
潜在买家名单
行销管道
- 直效行销
- 间接行销
- 行销通路发展趋势

第 5 章：全球消化不良药物市场分析：依适应症分类

按适应症概述
历史和预测数据
按指标分析
功能性消化不良
器质性消化不良

第 6 章：全球消化不良药物市场分析：依药物类型

按药物类型概述
历史和预测数据
依药物类型分析
质子帮浦抑制剂
H-2-受体拮抗剂
抗酸剂
抗生素
促动力
抗忧郁药

第 7 章：全球消化不良药物市场分析：依药物分类

按药物概述
历史和预测数据
按药物分析
品牌化
通用的

第 8 章：全球消化不良药物市场分析：按模式

按模式概述
历史和预测数据
按模式分析
在柜檯
处方

第 9 章：全球消化不良药物市场分析：按分销管道

按配销通路分類的概览
历史和预测数据
按配销通路分析
零售药局
医院药房
网路药局

第 10 章：全球消化不良药物市场分析：依地理位置

区域展望
介绍
北美销售分析
- 概览、历史与预测资料销售分析
- 北美按细分市场销售分析
- 北美按国家销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史与预测资料销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概览、历史与预测资料销售分析
- 亚太地区按细分市场销售分析
- 亚太地区国家/地区销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概览、历史与预测资料销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概览、历史与预测资料销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 11 章：消化不良药品公司的竞争格局

消化不良药物市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 12 章：公司简介

公司股份分析
市场集中度
Takeda Pharmaceutical Company Limited

公司简介
公司收入
产品
最近的发展

AstraZeneca plc.

公司简介
公司收入
产品
最近的发展

Salix Pharmaceuticals Inc.

公司简介
公司收入
产品
最近的发展

Abbott Laboratories

公司简介
公司收入
产品
最近的发展

Pfizer Inc.

公司简介
公司收入
产品
最近的发展

Sanofi SA

公司简介
公司收入
产品
最近的发展

Procter & Gamble

公司简介
公司收入
产品
最近的发展

Haleon plc

公司简介
公司收入
产品
最近的发展

ANI Pharmaceuticals Inc.

公司简介
公司收入
产品
最近的发展

Dr Reddy's Laboratories Ltd.

公司简介
公司收入
产品
最近的发展

注意 - 在公司概况中，财务详细资讯和近期发展视情况而定，或者如果是私人公司，则可能不包括在内

简介目录图表

Product Code: VMR112113353

The global demand for Dyspepsia Drugs Market is presumed to reach the market size of nearly USD 16.41 BN by 2032 from USD 10.3 BN in 2023 with a CAGR of 5.31% under the study period 2024 - 2032.

Dyspepsia drugs refer to medications or pharmaceutical treatments used to alleviate the symptoms of dyspepsia, a common digestive disorder characterized by discomfort or pain in the upper abdomen. Dyspepsia, often referred to as indigestion, can manifest with symptoms such as bloating, belching, nausea, and a feeling of fullness during or after meals. These drugs aim to relieve these symptoms and improve overall digestive well-being.

MARKET DYNAMICS

The Dyspepsia drugs market is driven by factors rooted in the prevalence of dyspepsia, a common digestive ailment characterized by symptoms like abdominal discomfort and indigestion. Modern lifestyles, including irregular eating habits and high-stress levels, contribute to the occurrence of dyspeptic symptoms, propelling the demand for drugs offering relief. Gastrointestinal disorders, such as GERD and peptic ulcers, often coexist with dyspepsia, further boosting the market. Aging populations and changing dietary habits contribute to the global demand, particularly among the elderly. Increased awareness, improved diagnostics, and over-the-counter availability of certain medications play pivotal roles in driving market growth. Ongoing technological advancements in drug development, a focus on combination therapies, and a patient-centric approach in healthcare further contribute to the dynamic landscape of the dyspepsia drugs market. As individuals seek effective pharmacological solutions for digestive discomfort, the market responds with innovative formulations and tailored treatments to meet diverse patient needs.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of dyspepsia drugs. The growth and trends of dyspepsia drugs industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the dyspepsia drugs market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Indication

Functional Dyspepsia
Organic Dyspepsia

By Drug Type

Proton Pump Inhibitors
H-2-Receptor Antagonists
Antacids
Antibiotics
Prokinetics
Antidepressants

By Medication

Branded
Generic

By Mode

Over-The-Counter
Prescription

By Distribution Channel

Retail Pharmacies
Hospital Pharmacies
Online Pharmacies

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Dyspepsia Drugs market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Dyspepsia Drugs market include Takeda Pharmaceutical Company Limited, AstraZeneca plc, Salix Pharmaceuticals Inc., Abbott Laboratories, Pfizer Inc., Sanofi SA, Procter & Gamble, Haleon plc, ANI Pharmaceuticals Inc., Dr Reddy's Laboratories Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . DYSPEPSIA DRUGS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Indication
- 3.7.2 Market Attractiveness Analysis By Drug Type
- 3.7.3 Market Attractiveness Analysis By Medication
- 3.7.4 Market Attractiveness Analysis By Mode
- 3.7.5 Market Attractiveness Analysis By Distribution Channel
- 3.7.6 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL DYSPEPSIA DRUGS MARKET ANALYSIS BY INDICATION

5.1 Overview by Indication
5.2 Historical and Forecast Data
5.3 Analysis by Indication
5.4 Functional Dyspepsia Historic and Forecast Sales by Regions
5.5 Organic Dyspepsia Historic and Forecast Sales by Regions

6 . GLOBAL DYSPEPSIA DRUGS MARKET ANALYSIS BY DRUG TYPE

6.1 Overview by Drug Type
6.2 Historical and Forecast Data
6.3 Analysis by Drug Type
6.4 Proton Pump Inhibitors Historic and Forecast Sales by Regions
6.5 H-2-receptor Antagonists Historic and Forecast Sales by Regions
6.6 Antacids Historic and Forecast Sales by Regions
6.7 Antibiotics Historic and Forecast Sales by Regions
6.8 Prokinetics Historic and Forecast Sales by Regions
6.9 Antidepressants Historic and Forecast Sales by Regions

7 . GLOBAL DYSPEPSIA DRUGS MARKET ANALYSIS BY MEDICATION

7.1 Overview by Medication
7.2 Historical and Forecast Data
7.3 Analysis by Medication
7.4 Branded Historic and Forecast Sales by Regions
7.5 Generic Historic and Forecast Sales by Regions

8 . GLOBAL DYSPEPSIA DRUGS MARKET ANALYSIS BY MODE

8.1 Overview by Mode
8.2 Historical and Forecast Data
8.3 Analysis by Mode
8.4 Over-the-counter Historic and Forecast Sales by Regions
8.5 Prescription Historic and Forecast Sales by Regions

9 . GLOBAL DYSPEPSIA DRUGS MARKET ANALYSIS BY DISTRIBUTION CHANNEL

9.1 Overview by Distribution Channel
9.2 Historical and Forecast Data
9.3 Analysis by Distribution Channel
9.4 Retail Pharmacies Historic and Forecast Sales by Regions
9.5 Hospital Pharmacies Historic and Forecast Sales by Regions
9.6 Online Pharmacies Historic and Forecast Sales by Regions

10 . GLOBAL DYSPEPSIA DRUGS MARKET ANALYSIS BY GEOGRAPHY

10.1. Regional Outlook
10.2. Introduction
10.3. North America Sales Analysis
- 10.3.1. Overview, Historic and Forecast Data Sales Analysis
- 10.3.2. North America By Segment Sales Analysis
- 10.3.3. North America By Country Sales Analysis
- 10.3.4. United State Sales Analysis
- 10.3.5. Canada Sales Analysis
- 10.3.6. Mexico Sales Analysis
10.4. Europe Sales Analysis
- 10.4.1. Overview, Historic and Forecast Data Sales Analysis
- 10.4.2. Europe by Segment Sales Analysis
- 10.4.3. Europe by Country Sales Analysis
- 10.4.4. United Kingdom Sales Analysis
- 10.4.5. France Sales Analysis
- 10.4.6. Germany Sales Analysis
- 10.4.7. Italy Sales Analysis
- 10.4.8. Russia Sales Analysis
- 10.4.9. Rest Of Europe Sales Analysis
10.5. Asia Pacific Sales Analysis
- 10.5.1. Overview, Historic and Forecast Data Sales Analysis
- 10.5.2. Asia Pacific by Segment Sales Analysis
- 10.5.3. Asia Pacific by Country Sales Analysis
- 10.5.4. China Sales Analysis
- 10.5.5. India Sales Analysis
- 10.5.6. Japan Sales Analysis
- 10.5.7. South Korea Sales Analysis
- 10.5.8. Australia Sales Analysis
- 10.5.9. South East Asia Sales Analysis
- 10.5.10. Rest Of Asia Pacific Sales Analysis
10.6. Latin America Sales Analysis
- 10.6.1. Overview, Historic and Forecast Data Sales Analysis
- 10.6.2. Latin America by Segment Sales Analysis
- 10.6.3. Latin America by Country Sales Analysis
- 10.6.4. Brazil Sales Analysis
- 10.6.5. Argentina Sales Analysis
- 10.6.6. Peru Sales Analysis
- 10.6.7. Chile Sales Analysis
- 10.6.8. Rest of Latin America Sales Analysis
10.7. Middle East & Africa Sales Analysis
- 10.7.1. Overview, Historic and Forecast Data Sales Analysis
- 10.7.2. Middle East & Africa by Segment Sales Analysis
- 10.7.3. Middle East & Africa by Country Sales Analysis
- 10.7.4. Saudi Arabia Sales Analysis
- 10.7.5. UAE Sales Analysis
- 10.7.6. Israel Sales Analysis
- 10.7.7. South Africa Sales Analysis
- 10.7.8. Rest Of Middle East And Africa Sales Analysis

11 . COMPETITIVE LANDSCAPE OF THE DYSPEPSIA DRUGS COMPANIES

11.1. Dyspepsia Drugs Market Competition
11.2. Partnership/Collaboration/Agreement
11.3. Merger And Acquisitions
11.4. New Product Launch
11.5. Other Developments

12 . COMPANY PROFILES OF DYSPEPSIA DRUGS INDUSTRY

12.1. Company Share Analysis
12.2. Market Concentration Rate
12.3. Takeda Pharmaceutical Company Limited
- 12.3.1. Company Overview
- 12.3.2. Company Revenue
- 12.3.3. Products
- 12.3.4. Recent Developments
12.4. AstraZeneca plc.
- 12.4.1. Company Overview
- 12.4.2. Company Revenue
- 12.4.3. Products
- 12.4.4. Recent Developments
12.5. Salix Pharmaceuticals Inc.
- 12.5.1. Company Overview
- 12.5.2. Company Revenue
- 12.5.3. Products
- 12.5.4. Recent Developments
12.6. Abbott Laboratories
- 12.6.1. Company Overview
- 12.6.2. Company Revenue
- 12.6.3. Products
- 12.6.4. Recent Developments
12.7. Pfizer Inc.
- 12.7.1. Company Overview
- 12.7.2. Company Revenue
- 12.7.3. Products
- 12.7.4. Recent Developments
12.8. Sanofi SA
- 12.8.1. Company Overview
- 12.8.2. Company Revenue
- 12.8.3. Products
- 12.8.4. Recent Developments
12.9. Procter & Gamble
- 12.9.1. Company Overview
- 12.9.2. Company Revenue
- 12.9.3. Products
- 12.9.4. Recent Developments
12.10. Haleon plc
- 12.10.1. Company Overview
- 12.10.2. Company Revenue
- 12.10.3. Products
- 12.10.4. Recent Developments
12.11. ANI Pharmaceuticals Inc.
- 12.11.1. Company Overview
- 12.11.2. Company Revenue
- 12.11.3. Products
- 12.11.4. Recent Developments
12.12. Dr Reddy's Laboratories Ltd.
- 12.12.1. Company Overview
- 12.12.2. Company Revenue
- 12.12.3. Products
- 12.12.4. Recent Developments